CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 150 filers reported holding CARA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.01 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,335,000 | +188.3% | 61,494 | +100.8% | 0.05% | +194.1% |
| Q4 2020 | $463,000 | +18.7% | 30,628 | 0.0% | 0.02% | -29.2% |
| Q3 2020 | $390,000 | -25.6% | 30,628 | 0.0% | 0.02% | -33.3% |
| Q2 2020 | $524,000 | -36.1% | 30,628 | -50.7% | 0.04% | -47.1% |
| Q1 2020 | $820,000 | +27.3% | 62,101 | +55.3% | 0.07% | +21.4% |
| Q4 2019 | $644,000 | -0.9% | 40,000 | +12.5% | 0.06% | -6.7% |
| Q3 2019 | $650,000 | -57.7% | 35,549 | -50.3% | 0.06% | -57.1% |
| Q2 2019 | $1,537,000 | +368.6% | 71,470 | +327.1% | 0.14% | +337.5% |
| Q1 2019 | $328,000 | -22.1% | 16,732 | -23.9% | 0.03% | -13.5% |
| Q2 2018 | $421,000 | -59.4% | 22,000 | -67.3% | 0.04% | -82.8% |
| Q2 2017 | $1,036,000 | -45.9% | 67,300 | -35.4% | 0.22% | -39.8% |
| Q1 2017 | $1,915,000 | – | 104,100 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ridgeback Capital Investments L.P. | 622,140 | $10,489,000 | 45.13% |
| RHO CAPITAL PARTNERS INC | 2,668,057 | $44,983,000 | 15.47% |
| Opaleye Management Inc. | 427,000 | $7,199,000 | 3.01% |
| DAFNA Capital Management LLC | 169,331 | $2,855,000 | 2.54% |
| Private Capital Advisors, Inc. | 246,850 | $4,162,000 | 1.80% |
| WALL STREET ASSOCIATES | 192,300 | $3,242,000 | 0.91% |
| SECTORAL ASSET MANAGEMENT INC | 1,212,578 | $20,444,000 | 0.87% |
| Virtus ETF Advisers LLC | 17,299 | $292,000 | 0.80% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 618,140 | $10,422,000 | 0.58% |
| SPHERA FUNDS MANAGEMENT LTD. | 197,820 | $3,335,000 | 0.49% |